Abstract
Glioblastoma multiforme (GBM) is an aggressive brain cancer with high inflammation levels that promote tumor growth and treatment resistance. The enzymes platelet-activating factor acetylhydrolase (PAF-AH) and secretory phospholipase A2 (sPLA2) play key roles in the GBM microenvironment, contributing to tumor progression. This study explores the inhibitory potential of non-steroidal anti-…